sorafenib fails in metastatic breast cancer
Published 13 years ago • 402 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
4:44
sorafenib extends survival in differentiated thyroid cancer
-
2:54
panacea trial and implications for pembrolizumab use in breast cancer
-
2:16
axitinib showed two-month advantage to sorafenib
-
2:13
panel ponders avastin's fate for breast cancer
-
3:29
bisphosphonates may reduce breast cancer risk
-
1:56
how clinicals trial differ from standard care in metastatic breast cancer treatment
-
57:35
exploring breakthrough treatments in metastatic breast cancer
-
4:06
sorafenib
-
7:48
advances in thyroid cancer the decison trial
-
0:28
here's a list of popular cancer drugs #cancer
-
6:29
sorafenib side effect management in thyroid cancer
-
1:42
fear and uncertainty with metastatic breast cancer
-
5:47
breast cancer risk factors: facts v. fiction with dr. leslie memsic of bedford breast center
-
5:02
judy boughey, sabcs 2022: breast conservation therapy in multiple ipsilateral breast cancer
-
1:05
tailoring radiation therapy for breast cancer based on recurrence risk
-
2:06
reimagining breast cancer
-
1:45
philip d. poorvu, md, on breast cancer treatment | dana-farber cancer institute
-
2:19
treatment optimization trials in breast cancer
-
0:59
treatment options for patients with advanced breast cancer with dr. farha
-
2:45
metastatic breast cancer research initiative
-
2:59
critical issues facing the advanced breast cancer patient community
-
2:38
breast cancer overdiagnosis may not happen as frequently as previously thought